Nimmon Cyril C, Sámal Martin, Britton Keith E
Chiang Mai, Thailand. Institute of Nuclear Medicine, 1st Faculty of Medicine, Charles University Prague, Prague, Czech Republic.
J Nucl Med. 2004 Apr;45(4):587-93.
One of the potential limitations in the usefulness of both renal output efficiency (ROE) and normalized residual activity (NORA) is their residual dependence on total renal function. The purpose of this study was to present and examine a new quantitative method whereby the effects of this dependence may be removed.
The analytic method involves the determination of a retention function using an unconstrained matrix algorithm deconvolution technique followed by reconvolution with a chosen standard input function to yield a new secondary renal activity time (A/T) curve from which normalized values of ROE and NORA, denoted as N_ROE and N_NORA, respectively, can then be obtained using conventional definitions. The method has been applied in a series of 50 patient studies, which had been acquired using (99m)Tc-mercaptoacetyltriglycine (99(m)Tc-MAG3) and a standard F+18 furosemide protocol, with values of the ratio of plasma clearance to plasma volume (C/V) in the range 0.013-0.242 min(-1).
Pre- and postnormalization values of NORA, calculated at 30 min after injection, showed a significant difference in mean values (paired t test; P < 0.001), with a maximum observed difference, DeltaNORA(30), of -4.82 (-482%) and with a SD on the paired differences, DeltaNORA(30), of 0.56 (56%) or 0.63 (63%) if background subtraction on the input function (BSIF) had been performed. In contrast, corresponding values of ROE showed a nonsignificant difference in means (P > 0.05) and a SD on the paired differences, DeltaROE(30), of 3.7% or 3.2% with and without BSIF, respectively. The normalized parameters N_ROE and N_NORA were found to be strongly linearly correlated (r = -0.99; P < 0.001), in agreement with theoretical predictions.
These results suggest that renal function affects NORA significantly more than ROE. The effects can be corrected by our normalization technique, resulting in equivalent values of normalized ROE and normalized NORA.
肾输出效率(ROE)和标准化残余活性(NORA)实用性的潜在局限之一是它们仍依赖于总肾功能。本研究的目的是提出并检验一种新的定量方法,借此消除这种依赖性的影响。
该分析方法包括使用无约束矩阵算法反卷积技术确定保留函数,随后与选定的标准输入函数进行再卷积,以生成新的次级肾活性时间(A/T)曲线,然后可使用传统定义从中获得ROE和NORA的标准化值,分别记为N_ROE和N_NORA。该方法已应用于一系列50例患者研究,这些研究使用(99m)锝-巯基乙酰三甘氨酸(99mTc-MAG3)和标准F+18速尿方案进行,血浆清除率与血浆体积之比(C/V)的值在0.013-0.242 min⁻¹范围内。
注射后30分钟计算的NORA归一化前后值显示平均值有显著差异(配对t检验;P<0.001),最大观察差异DeltaNORA(30)为-4.82(-482%),配对差异DeltaNORA(30)的标准差为0.56(56%),如果对输入函数进行背景扣除(BSIF)则为0.63(63%)。相比之下,ROE 的相应值在平均值上无显著差异(P>0.05),配对差异DeltaROE(30)的标准差分别为3.7%(有BSIF时)或3.2%(无BSIF时)。发现标准化参数N_ROE和N_NORA高度线性相关(r=-0.99;P<0.001),与理论预测一致。
这些结果表明肾功能对NORA的影响明显大于对ROE的影响。通过我们的归一化技术可以校正这些影响,从而得到标准化ROE和标准化NORA的等效值。